Orthobiologics in minimally invasive lumbar fusion
- PMID: 31380488
- PMCID: PMC6626751
- DOI: 10.21037/jss.2019.04.15
Orthobiologics in minimally invasive lumbar fusion
Abstract
Minimally invasive (MI) spine surgery continues to gain popularity with patients and surgeons for its potential to decrease operative time and avoid complications commonly associated with open surgery. In the face of a changing surgical landscape, selecting the appropriate implant material to be used in MI lumbar fusion procedures will remain critically important. Various orthobiologic materials are available for use, including autologous and allogeneic bone graft, bone marrow aspirate (BMA), demineralized bone matrix (DBM), ceramics, and growth factors. The purpose of this review is to summarize the use and efficacy of currently available products, as well as highlight the development of novel therapeutic options.
Keywords: Minimally invasive (MI); bone graft; peptide amphiphile (PA); rhBMP-2; spinal fusion.
Conflict of interest statement
Conflicts of Interest: WK Hsu has received research grant from Wright Medical and IP royalties from Stryker; advisory board for the Journal of Bone and Joint Surgery; consulted for Stryker, Medtronic, Mirus, Allosource, Biovenus, Micromedicine, and Agnovos. AC Greene has no conflicts of interest to declare.
Figures
References
Publication types
LinkOut - more resources
Full Text Sources